News

Organise, share and protect your documents with the e-DOC web platform. e-DOC is a web-based document management platform for any type of company.
e-DOC simplifies document management and allows you to organise them with the typical logic of digital tools.
e-DOC provides a centralised area for file storage, enabling users to access, share and collaborate on documents securely. e-DOC is a powerful tool for managing the entire document lifecycle. e-DOC increases productivity, facilitates sharing, enhances data security and integrity, improves workflow, reduces costs, reduces errors, improves customer relations, enables document classification and easy file searching.

e-FORM is a software platform used by Pharmaceutical Industries, CROs, Scientific Societies and Universities to manage every type of clinical studies.
It is a digital solution that enables real-time collection and validation of data from different sources (data entered by investigators, patients or automatically imported also from wearable devices) and comprehensive management of centralised, hybrid and decentralised studies.
e-FORM allows monitoring the progress of clinical studies, web-based collection of patient data (e-crf) and real-time statistics.
Clinical research projects in many therapeutic areas (pulmonology, cardiology, oncology, gastroenterology, nephrology, neurology, etc.), device and nutraceutical studies, and non-profit studies are successfully managed using the e-FORM software.
Everything you need for clinical studies, in one online solution.

On 24/10/2024 elections were held for the renewal of the Board of Directors of Piccola Industria Group of Confindustria Genova.
Rosalba Brizzolara, CEO of Dreams Lab, was confirmed in the new Board.

Rosalba Brizzolara, CEO of Dreams Lab, has been reconfirmed on the board of Dixet, the High Tech Business Group of Confindustria Genova.

e-FORM is currently used by a Scientific Society to manage the collection of data of a clinical study in Pneumology. The software is gathering via Internet data of 3000 patients in 100 trial centers.